...cell inducer and a T cell activator.Cambridge accelerator Start Codon closes first fundU.K.-based life sciences accelerator Start Codon...
...million ($19.8 million). Novartis AG (NYSE:NVS; SIX:NOVN) and Cambridge Innovation Capital were among its LPs. Start Codon...
...shares in the deal. TARGETSC3 - Complement 3NMT – N-myristoyltransferase BC Staff Lead Pharma Holding B.V. Apellis Pharmaceuticals Inc. BeyondSpring Inc. Start Codon Myricx...

...Cambridge to develop next generation antibody-drug conjugate (ADC) therapeutics to treat multiple cancers. Meltwind and Start Codon...

...of the Milner Therapeutics Institute, a Cambridge-based translational research hub. On April 23, Milner launched Start Codon...

...to provide capital, mentorship and lab space to young companies. That’s the rationale for launching Start Codon...
...investor group that includes CIC, Genentech Inc. and research campus operator Babraham Bioscience Technologies Ltd., Start Codon...
...regular basis, so we see Start Codon as an extension of CIC for early stage opportunities.” Start Codon’s...

...promoters and express proteins from endogenous genes - even those that do not contain a start codon...